DCB Bank Regulatory Approval

Employee Stock Options

DCB Bank Employee Stock Options

DCB Bank allotted 81,100 equity shares to employees under its ESOP plan on October 30, 2026. Paid-up capital rose to 322,270,512 shares.

Annual General Meeting

DCB Bank Annual General Meeting

DCB Bank seeks shareholder approval via postal ballot to re-appoint Thiyagarajan Kumar as Independent Director for three years. E-voting runs from 27 October to 25 November 2026.

Earnings Call

DCB Bank Earnings Call Transcript: Key Takeaways

DCB Bank delivers record quarterly net profit, hitting long-term ROE targets early despite NIM compression.

Call

Guides 20% growth

Management Change

DCB Bank Management Change

DCB Bank's board re-appointed Mr. Praveen Kutty as Managing Director & CEO for three years from April 29, 2027 to April 28, 2030, subject to RBI terms and shareholder approval. No monetary value is involved in this senior management decision.

Execution

April 29, 2027 to April 28, 2030

Earnings Call

DCB Bank Investor Presentation: Key Takeaways

Q2FY27 PAT INR 236 cr (+28.54% YoY); advances INR 64,127 cr (+21.05%); deposits INR 76,839 cr (+18.62%); GNPA 2.29%, NNPA 0.73%, ROE 14.60%. Secured retail and MSME growth focus.

Financial Results

DCB Bank Q2 FY27 Results: Net Profit ₹236.4 Cr, Up 28.5% YoY

DCB Bank Ltd reported revenue from operations of ₹2,050 Cr (+12.5% YoY) and net profit of ₹236.4 Cr (+28.5% YoY) for Q2 FY27.

Key figure

Net profit ₹236.4 Cr · +28.5% YoY

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.